Director · Theravance Biopharma, Inc. · Theravance Biopharma, Inc. — Share Option (Right to Buy)
Side
D
Value
—
Shares
32.7K
Price
—
Executed
Sep 23, 2026
Disclosed
Sep 24, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Sep 23 executedSep 24, 2026 disclosed
TBPH · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disposition to issuer — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Theravance Biopharma, Inc. — Share Option (Right to Buy)
Ticker
TBPH
Shares
32.7K
Execution date (reported)
Sep 23, 2026
Owned after transaction
0 shares
Days from execution to publication
1
What this establishes
Gray Susannah filed this Form 4 reporting a disposition to issuer of TBPH on Sep 23, 2026. It became public on Sep 24, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Gray Susannahcik:0001833453
Issuer
Theravance Biopharma, Inc.cik:0001583107
Revision history · 0
No field has changed since this record was first ingested.
